Liedekerke advised 3i portfolio company Havea on the deal. Havea Group, one of the European leaders in natural health products, acquired ixX pharma, a key Belgian…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
